COMMUNIQUÉS West-GlobeNewswire

STERIS to Host a Conference Call for Fiscal 2020 First Quarter Financial Results on August 6, 2019
23/07/2019
Dublin, Ireland, July 23, 2019 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2020 first quarter financial results at 10: [...]
Retrophin to Report Second Quarter 2019 Financial Results
23/07/2019
SAN DIEGO, July 23, 2019 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced it will report second quarter 2019 financial results on Tuesday, August 6, 2019 after the close of the U.S. financial markets. [...]
OrthoPediatrics Corp. Receives FDA 510(k) Clearance for Next Generation Cannulated Screw System
23/07/2019
WARSAW, Ind., July 23, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today it has received [...]
IRIDEX to Report Second Quarter 2019 Financial Results on August 6, 2019
23/07/2019
MOUNTAIN VIEW, Calif., July 23, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the second quarter of 2019 after the close of trading on Tuesday [...]
Adamas to Announce Second Quarter 2019 Financial Results and Host Conference Call on August 8, 2019
23/07/2019
EMERYVILLE, Calif., July 23, 2019 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the company will report 2019 second quarter financial results on Thursday, August 8, 2019, after [...]
SI-BONE To Report Second Quarter 2019 Financial Results on August 6, 2019
23/07/2019
SANTA CLARA, Calif., July 23, 2019 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report [...]
Shockwave Medical to Participate in the 39th Annual Canaccord Genuity Global Growth Conference
23/07/2019
SANTA CLARA, Calif., July 23, 2019 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified [...]
Shockwave Medical to Report Second Quarter 2019 Financial Results on August 5, 2019
23/07/2019
SANTA CLARA, Calif., July 23, 2019 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified [...]
Repligen to Report Second Quarter 2019 Financial Results
23/07/2019
Webcast and Conference Call to Be Held Thursday, August 1, 2019 at 8:30 a.m. EDT WALTHAM, Mass., July 23, 2019 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its [...]
Jounce Therapeutics Announces Update on Strategic Collaboration with Celgene Corporation
23/07/2019
- Celgene licenses JTX-8064, resulting in $50.0 million upfront payment to Jounce - - Jounce retains full worldwide rights to vopratelimab, JTX‑4014 and all discovery programs - - Company to host conference call and [...]
GW Pharmaceuticals plc to Report Financial Results and Operational Progress for the Period Ending June 30, 2019 and Host Conference Call on August 6, 2019
23/07/2019
LONDON, July 23, 2019 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH, “GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its [...]
OSE Immunotherapeutics Receives a Grant from the French National Research Agency to Validate New Targets Linked to Myeloid Cells And Identify Innovative New Immunotherapies in Oncology
23/07/2019
Research program coordinated by the Cancer Research Center of Lyon within the Léon Bérard Cancer Center NANTES, France, July 23, 2019 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics (ISIN: FR0012127173; Mnemo: OSE) announces [...]
Eurobio Scientific's Activity for the First Half of 2019: Strong Growth of Sales
23/07/2019
ACTIVITY FOR THE FIRST HALF OF 2019: STRONG GROWTH OF SALES Consolidated half-year turnover up 18% at € 29.5 million mainly driven by new distributions and new customers Paris, July 23 2019 – 17:45 pm Eurobio Scientific [...]
EUROBIO SCIENTIFIC : ACTIVITÉ DU PREMIER SEMESTRE 2019 EN FORTE PROGRESSION
23/07/2019
ACTIVITÉ DU PREMIER SEMESTRE 2019 EN FORTE PROGRESSION Progression du chiffre d’affaires semestriel consolidé de +18% à 29,5 M€ principalement portée par les nouvelles distributions et les nouveaux clients Paris, le 23 [...]
Genmab Announces the Closing of Over-Allotment Option in Initial Public Offering of American Depositary Shares (ADSs) in the United States and Registration of Capital Increase
23/07/2019
Company Announcement Genmab A/S has today completed the closing of the exercise in full by the underwriters of their over-allotment option in connection with its initial public offering of American Depositary Shares in [...]
Nordic Transport Group Holding announces mandatory public takeover offer
23/07/2019
Company announcement 23 July 2019 Nordic Transport Group Holding announces mandatory public takeover offer NeuroSearch A/S ("NeuroSearch") has received notice from Nordic Transport Group Holding A/S ("NTG Holding") that [...]
Medtronic Canada Recognized as One of the Best Workplaces™ in Healthcare in 2019
23/07/2019
Sense of pride and camaraderie identified as key attributes BRAMPTON, Ontario, July 23, 2019 (GLOBE NEWSWIRE) -- Medtronic Canada ULC, a subsidiary of Medtronic plc (NYSE:MDT) --- one of the world’s largest medical [...]
MEDTRONIC CANADA RECONNUE COMME L’UN DES MEILLEURS LIEUX DE TRAVAIL EN SOINS DE SANTÉ POUR L’ANNÉE 2019
23/07/2019
Le sentiment de fierté et la camaraderie sont des attributs distinctifs BRAMPTON, Ontario, 23 juill. 2019 (GLOBE NEWSWIRE) -- Medtronic Canada ULC, une filiale de Medtronic plc (NYSE : MDT), l ’ une des plus grandes [...]
Major shareholder announcement
23/07/2019
Company announcement 23 July 2019 Major shareholder announcement Pursuant to section 30 of Consolidated Act no. 459 of 24 April 2019 on capital markets, as amended, NeuroSearch A/S ("NeuroSearch") hereby announces to [...]

Pages